FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35130011000001100: Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Mar 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
584081000001116 Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
584091000001119 Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Is a Lidocaine 10mg / Cetrimide 100microgram oromucosal spray sugar free true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has specific active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has specific active ingredient Cetrimide true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Is a Xylonor true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Has active ingredient Cetrimide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) 36 gram Has AMP True Xylonor 150mg/g / 1.5mg/g oromucosal spray (Septodont Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start